Cargando…

Expression of Concern: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024868/
https://www.ncbi.nlm.nih.gov/pubmed/33821978
http://dx.doi.org/10.1042/BSR-20190094_EOC
_version_ 1783675399540047872
collection PubMed
description
format Online
Article
Text
id pubmed-8024868
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80248682021-04-15 Expression of Concern: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism Biosci Rep Expression of Concern Portland Press Ltd. 2021-04-06 /pmc/articles/PMC8024868/ /pubmed/33821978 http://dx.doi.org/10.1042/BSR-20190094_EOC Text en © 2021 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Expression of Concern
Expression of Concern: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism
title Expression of Concern: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism
title_full Expression of Concern: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism
title_fullStr Expression of Concern: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism
title_full_unstemmed Expression of Concern: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism
title_short Expression of Concern: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism
title_sort expression of concern: progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a bcl-2/beclin1-dependent mechanism
topic Expression of Concern
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024868/
https://www.ncbi.nlm.nih.gov/pubmed/33821978
http://dx.doi.org/10.1042/BSR-20190094_EOC